Tomasz Rygiel

Company: Cellis

Job title: CEO

Seminars:

Breakthrough Macrophage Based Immunotherapy for Treatment of Solid Tumors 2:30 pm

Macrophage Drug Conjugates (MDCs) are an innovative allogeneic therapy for solid tumors Examine how MDCs eliminate or significantly shrink tumors in mouse models, including orthotopic human cancer models in SCID mice Gain an update on the first MDC drug candidate, expected to enter human clinical trials for glioblastoma in 2024Read more

day: Day One